Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Effects of Enhanced External Counterpulsation Combined With Cardiac Rehabilitation in Patients With Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- Atrial Fibrillation (AF)Heart Failure (HF)Cardiac Rehabilitation
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Lanzhou University Second Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT07058987
- Locations
- 🇨🇳
Lanzhou University Second Hospital, Lanzhou, Gansu, China
Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection
Completed
- Conditions
- TumorsPET / CTFDG PET/CTFAPI
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Lanzhou University Second Hospital
- Target Recruit Count
- 27
- Registration Number
- NCT06945432
- Locations
- 🇨🇳
The Second Hospital of Lanzhou University, Lanzhou, Gansu, China
Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients
Completed
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer
- First Posted Date
- 2024-10-24
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Lanzhou University Second Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT06657755
- Locations
- 🇨🇳
Lanzhou University Second Hospital, Lanzhou, Gansu, China
News
No news found